SynthesisHepatology international2024

TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors versus TACE plus tyrosine kinase inhibitors for the treatment of patients with hepatocellular carcinoma: a meta-analysis and trial sequential analysis.

Jiaxi Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.